Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by French, J. E.
Right arrow Articles by Tennant, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by French, J. E.
Right arrow Articles by Tennant, R. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 1, 99-106, January 2001
© 2001 Oxford University Press

CANCER BIOLOGY

Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/–) mouse tumors is carcinogen-and tissue-dependent

John E. French1,4, Gregory D. Lacks1,2, Carol Trempus1, June K. Dunnick1, Julie Foley3, Joel Mahler3, Raymond R. Tice2 and Raymond W. Tennant1

1 Laboratory of Environmental Mutagenesis and Carcinogenesis, and
2 Integrated Laboratory Systems, Research Triangle Park, NC 27709, USA and
3 Laboratory of Experimental Pathology, NIEHS

Mutagenic carcinogens rapidly induced tumors in the p53 haploinsufficient mouse. Heterozygous p53-deficient (+/–) mice were exposed to different mutagenic carcinogens to determine whether p53 loss of heterozygosity (LOH) was carcinogen-and tissue-dependent. For 26 weeks, C57BL/6 (N5) p53-deficient (+/–) male or female mice were exposed to p-cresidine, benzene or phenolphthalein. Tumors were examined first for loss of the wild-type p53 allele. p-cresidine induced p53 LOH in three of 13 bladder tumors, whereas hepatocellular tumors showed p53 LOH in carcinomas (2/2), but not in adenomas (0/3). Benzene induced p53 LOH in 13 of 16 tumors examined. Finally, phenolphthalein induced p53 LOH in all tumors analyzed (21/21). Analysis of the p-cresidine-induced bladder tumors by cold single-strand conformation polymorphism (SSCP) analysis of exon 4–9 amplicons failed to demonstrate polymorphisms associated with mutations in tumors that retained the p53 wild-type allele. p-cresidine induced a dose-related increase in lacI mutations in bladder DNA. In summary, these data demonstrate that loss of the wild-type allele occurred frequently in thymic lymphomas and sarcomas, but less frequently in carcinomas of the urinary bladder. In the bladder carcinomas other mechanisms may be operational. These might include (i) other mechanisms of p53 inactivation, (ii) inactivating mutations occurring outside exons 4–9 or (iii) p53 haploinsufficiency creating a condition that favors other critical genetic events which drive bladder carcinogenesis, as evidenced by the significant decrease in tumor latency. Understanding the mechanisms of p53 LOH and chemical carcinogenesis in this genetically altered model could lead to better models for prospective identification and understanding of potential human carcinogens and the role of the p53 tumor suppressor gene in different pathways of chemical carcinogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
H. Tazawa, M. Tatemichi, T. Sawa, I. Gilibert, N. Ma, Y. Hiraku, L. A. Donehower, H. Ohgaki, S. Kawanishi, and H. Ohshima
Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53+/- mice
Carcinogenesis, January 1, 2007; 28(1): 191 - 198.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. A. Hill, V. L. Buettner, A. Heidt, L.-L. Chen, W. Li, K. D. Gonzalez, J.-C. Wang, W. A. Scaringe, and S. S. Sommer
Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype
Carcinogenesis, September 1, 2006; 27(9): 1860 - 1866.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Jaworski, S. Hailfinger, A. Buchmann, M. Hergenhahn, M. Hollstein, C. Ittrich, and M. Schwarz
Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53
Carcinogenesis, October 1, 2005; 26(10): 1829 - 1834.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
Y. Hirabayashi, B.-I. Yoon, G.-X. Li, J. Kanno, and T. Inoue
Mechanism of Benzene-Induced Hematotoxicity and Leukemogenicity: Current Review with Implication of Microarray Analyses
Toxicol Pathol, February 1, 2004; 32(2_suppl): 12 - 16.
[Abstract] [PDF]

Home page
 Toxicol SciHome page
C. A. Vaslet, N. J. Messier, and A. B. Kane
Accelerated Progression of Asbestos-Induced Mesotheliomas in Heterozygous p53+/- Mice
Toxicol. Sci., August 1, 2002; 68(2): 331 - 338.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
S. Venkatachalam, S. D. Tyner, C. R. Pickering, S. Boley, L. Recio, J. E. French, and L. A. Donehower
Is p53 Haploinsufficient for Tumor Suppression? Implications for the p53+/- Mouse Model in Carcinogenicity Testing
Toxicol Pathol, January 1, 2001; 29(1_suppl): 147 - 154.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.